Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia
Open Access
- 25 May 2016
- journal article
- Published by Springer Nature in Leukemia
- Vol. 30 (8) , 1691-1700
Abstract
Lack of suitable in vitro culture conditions for primary acute lymphoblastic leukaemia (ALL) cells severely impairs their experimental accessibility and the testing of new drugs on cell material reflecting clonal heterogeneity in patients. We show that Nestin-positive human mesenchymal stem cells (MSC) support expansion of a range of biologically and clinically distinct patient-derived ALL samples. Adherent ALL cells showed an increased accumulation in the S-phase of the cell cycle and diminished apoptosis when compared to cells in the suspension fraction. Moreover, surface expression of adhesion molecules CD34, CDH2 and CD10 increased several folds. About 20% of the ALL cells were in G0 phase of the cell cycle suggesting that MSCs may support quiescent ALL cells. Cellular barcoding demonstrated long-term preservation of clonal abundance. Expansion of ALL cells for more than 3 months compromised neither feeder dependence nor cancer initiating ability as judged by their engraftment potential in immunocompromised mice. Finally, we demonstrate the suitability of this co-culture approach for the investigation of drug combinations with luciferase-expressing primograft ALL cells. Taken together, we have developed a preclinical platform with patient-derived material that will facilitate the development of clinically effective combination therapies for ALL.Keywords
This publication has 56 references indexed in Scilit:
- Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κBClinical Cancer Research, 2013
- Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populationsEMBO Molecular Medicine, 2012
- Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemiaLeukemia, 2012
- Raise standards for preclinical cancer researchNature, 2012
- BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibitionNature, 2011
- Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonistLeukemia, 2011
- Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapseJournal of Experimental Medicine, 2011
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell linesJournal of Biomedical Science, 2010
- In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell PropertiesCancer Cell, 2008